Arguments for paying generic drug makers to abandon patent challenges may rest on dubious assumptions.
C. Scott Hemphill and Bhaven Sampat, SCIENCE Magazine, Vol 339, 22 March 2013.
Click here to read the full article online
Arguments for paying generic drug makers to abandon patent challenges may rest on dubious assumptions.